SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-045574
Filing Date
2021-04-01
Accepted
2021-04-01 16:15:43
Documents
3
Period of Report
2021-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2111285d1_8k.htm 8-K 17314
2 EXHIBIT 99.1 tm2111285d1_ex99-1.htm EX-99.1 82770
3 GRAPHIC tm2111285d1_ex99-1img01.jpg GRAPHIC 27661
  Complete submission text file 0001104659-21-045574.txt   139580
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 21798165
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences